Northern Trust’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$113K Hold
22,673
﹤0.01% 4085
2025
Q1
$182K Hold
22,673
﹤0.01% 3973
2024
Q4
$168K Buy
+22,673
New +$168K ﹤0.01% 4036
2023
Q4
Sell
-45
Closed -$1.31K 4478
2023
Q3
$1.31K Hold
45
﹤0.01% 4458
2023
Q2
$3.85K Hold
45
﹤0.01% 4518
2023
Q1
$19K Hold
45
﹤0.01% 4458
2022
Q4
$54.7K Hold
45
﹤0.01% 4263
2022
Q3
$36K Buy
45
+5
+13% +$4K ﹤0.01% 4411
2022
Q2
$58K Sell
40
-146
-78% -$212K ﹤0.01% 4365
2022
Q1
$388K Buy
186
+1
+0.5% +$2.09K ﹤0.01% 3840
2021
Q4
$907K Buy
185
+5
+3% +$24.5K ﹤0.01% 3580
2021
Q3
$1.13M Sell
180
-33
-15% -$207K ﹤0.01% 3512
2021
Q2
$2.01M Buy
213
+26
+14% +$245K ﹤0.01% 3352
2021
Q1
$1.62M Buy
187
+12
+7% +$104K ﹤0.01% 3360
2020
Q4
$1.33M Buy
175
+11
+7% +$83.7K ﹤0.01% 3394
2020
Q3
$1.07M Buy
164
+41
+33% +$268K ﹤0.01% 3368
2020
Q2
$920K Buy
123
+25
+26% +$187K ﹤0.01% 3386
2020
Q1
$703K Buy
98
+19
+24% +$136K ﹤0.01% 3352
2019
Q4
$1.22M Sell
79
-2
-2% -$31K ﹤0.01% 3327
2019
Q3
$769K Buy
81
+62
+326% +$589K ﹤0.01% 3459
2019
Q2
$304K Buy
19
+6
+46% +$96K ﹤0.01% 3694
2019
Q1
$222K Buy
13
+6
+86% +$102K ﹤0.01% 3752
2018
Q4
$65K Buy
7
+2
+40% +$18.6K ﹤0.01% 4000
2018
Q3
$63K Hold
5
﹤0.01% 4105
2018
Q2
$59K Sell
5
-6
-55% -$70.8K ﹤0.01% 4100
2018
Q1
$135K Buy
11
+7
+175% +$85.9K ﹤0.01% 3902
2017
Q4
$36K Buy
+4
New +$36K ﹤0.01% 4102